As of 2:27pm ET
| -0.0129 / -5.54%|
The 1 analysts offering 12-month price forecasts for Mateon Therapeutics Inc have a median target of 0.55, with a high estimate of 0.55 and a low estimate of 0.55. The median estimate represents a +150.00% increase from the last price of 0.22.
The current consensus among 1 polled investment analysts is to Buy stock in Mateon Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.